NCT04920630

Brief Summary

The primary aim of this study is to understand how insomnia contributes to chronic pain in youth. Specifically, the investigators are interested in how insomnia and the treatment of insomnia impact emotional states and the body's ability to efficiently modulate pain, either to increase or decrease pain perception. It is hypothesized that insomnia is associated with increased negative emotional states and impaired pain modulation, which will improve after treatment of insomnia. In this project, the objectives are to 1) evaluate the role of pain modulation as a potential mechanism through which insomnia impacts pain symptoms, and 2) evaluate the role of negative affect as mediators of the impact of insomnia on pain modulation. Study participation will consist of a baseline assessment, a 5 session (once per week) virtual group cognitive behavioral therapy for insomnia (CBT-I) intervention, and a follow-up assessment. Investigators will also ask teen participants to complete the consensus sleep diary daily for 7 days prior to the baseline and follow up study visits. Assessment visits will consist of two types of assessments, questionnaires and quantitative sensory testing (QST). Participating parents and teens will complete questionnaires (both child and parent report) assessing the child's pain, sleep, and psycho-social variables. QST will assess pain inhibition via conditioned pain modulation (CPM) and pain facilitation via temporal summation (TS).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 10, 2021

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

May 27, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 10, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2023

Completed
Last Updated

August 23, 2023

Status Verified

August 1, 2023

Enrollment Period

2 years

First QC Date

May 27, 2021

Last Update Submit

August 21, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from baseline Conditioned Pain Modulation (CPM)

    Heat pain threshold (test stimulus) will be assessed on the volar surface of the dominant forearm twice before before, during, and after immersion (for 1 minute) of the non-dominant hand in a circulated cold-water bath (conditioning stimulus) maintained at 5˚C ±1˚C. Heat pain threshold will be assessed via the method of limits. Subjects will be instructed to push a button as soon as the heat feels painful, which will stop the trial. Immediately before and after the CPM assessment, the subjects' non-dominant hand will be placed in a room-temperature water bath (20-25˚C) for 2 minutes. The CPM effect will be calculated as a difference score: heat pain threshold during conditioning stimulus minus baseline. A negative score indicates pain inhibition.

    1-4 weeks post-treatment

  • Change from baseline Temporal Summation of Pain (TS)

    Temporal summation will be assessed via a series of 10 brief (\~0.5s duration for peak, total time for heating, peak, and cooling \<1.5s) heat pulses (48˚C) delivered via a Medoc Thermal Sensory Analyzer-2 thermode positioned on the volar surface of the forearm. Time between each peak will be 3 seconds. Subjects will provide a verbal pain rating immediately after the first and last heat pulse is delivered. Pain ratings will be made on a 0-100 numerical rating scale (0=no pain, 100=most pain imaginable), which will be displayed during the assessment. Temporal summation will be calculated as a difference score (i.e., pain during final stimulus minus pain during initial stimulus), with a positive score indicating pain facilitation due to temporal summation.

    1-4 weeks post-treatment

Secondary Outcomes (4)

  • Change from baseline score on Generalized Anxiety Disorder -7

    1-4 weeks post-treatment

  • Change from baseline score on Patient Health Questionnaire - 9 Adolescent Form (PHQ9-A).

    1-4 weeks post-treatment

  • Change from Baseline Score on Positive and Negative Affect Schedule (PANAS)

    1-4 weeks post-treatment

  • Change from baseline score on Pediatric Insomnia Severity Index (PISI)

    1-4 weeks post-treatment

Study Arms (1)

CBT-I

EXPERIMENTAL

5-weekly Cognitive Behavioral Therapy for Insomnia group therapy sessions conducted virtually.

Behavioral: Cognitive Behavioral Therapy - Insomnia (CBT-I)

Interventions

CBT-I will be delivered via 5 weekly virtual group therapy sessions. Session content is manualized and adapted from existing CBT-I protocols to be relevant to a virtual adolescent group and will include: Session 1 - Introduction of group members, group rules, psychoeducation regarding sleep, and instructions on completion of sleep log. Session 2 - Review sleep log, sleep hygiene, relaxation training, and stimulus control. Session 3 - Review sleep log, sleep restriction, and cognitive strategies (positive self-statements, worry management). Session 4 - Review sleep log and sleep restriction, and problem-solving barriers. Session 5 - Maintenance and relapse prevention.

Also known as: CBT-I
CBT-I

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Aged 12 to 17 years.
  • Meets criteria for insomnia with or without comorbid chronic musculoskeletal pain.
  • Parent/guardian available to provide consent.
  • Patient and a primary caregiver are able to independently read and understand English well enough to provide informed consent and complete study procedures.
  • Access to email, internet, and audio and video call capabilities.
  • Parent/legal guardian of a child meeting above eligibility criteria
  • Able to independently read and understand English well enough to provide informed consent and complete study questionnaires.

You may not qualify if:

  • History of cardiac or neuromuscular disorder
  • Parent-report of child's use of Opioid medications (i.e., fentanyl, morphine, hydromorphone, methadone, hydrocodone, oxycodone) that cannot be discontinued for 7 days prior to study visits.
  • Inadequate proficiency in English or a developmental disability that interferes with informed consent/assent or completion of study procedures.
  • History of obstructive sleep apnea, restless leg syndrome, or narcolepsy.
  • History of bipolar disorder and/or manic episodes
  • Diagnosis of epilepsy.
  • Currently in foster care or considered a ward of the state.
  • History of Raynaud Syndrome.
  • Active suicidal ideation, intent or plan in the past month.
  • Inadequate proficiency in English or a developmental disability that interferes with informed consent or completion of questionnaires.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Riley Hospital for Childre

Indianapolis, Indiana, 46202, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersChronic Pain

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Clinical Psychiatry

Study Record Dates

First Submitted

May 27, 2021

First Posted

June 10, 2021

Study Start

May 10, 2021

Primary Completion

May 5, 2023

Study Completion

May 5, 2023

Last Updated

August 23, 2023

Record last verified: 2023-08

Locations